The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 101-59-87
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2024
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Khatkov I.E.

Loginov Moscow Clinical Scientific Practical Center

Alikhanov R.B.

Loginov Moscow Clinical Scientific Practical Center

Bedin V.V.

Burnazyan State Scientific Center

Breder V.V.

Botkin Moscow City Clinical Hospital

Britskaya N.N.

Loginov Moscow Clinical Scientific Practical Center

Voskanyan S.E.

Granov Russian Research Center of Radiology and Surgical Technologies

Vishnevsky V.A.

Vishnevsky National Research Center of Surgery

Granov D.A.

Blokhin National Cancer Research Center

Zhukova L.G.

Loginov Moscow Clinical Scientific Practical Center

Zagainov V.E.

National Medical Research Radiological Center

Kovalenko D.E.

Loginov Moscow Clinical Scientific Practical Center

Koroleva A.A.

Loginov Moscow Clinical Scientific Practical Center

Kulezneva Yu.V.

Loginov Moscow Clinical Scientific Practical Center

Melekhina O.V.

Loginov Moscow Clinical Scientific Practical Center

Nazarenko A.V.

Loginov Moscow Clinical Scientific Practical Center

Odintsova M.V.

Blokhin National Cancer Research Center

Petrov L.O.

Novosibirsk Regional State Hospital

Pogrebnyakov I.V.

Botkin Moscow City Clinical Hospital

Podluzhny D.V.

Botkin Moscow City Clinical Hospital

Polyakov A.N.

Botkin Moscow City Clinical Hospital

Porshennikov I.A.

Nizhny Novgorod Regional Clinical Oncology Dispensary

Rutkin I.O.

Blokhin National Cancer Research Center

Semenov N.N.

Loginov Moscow Clinical Scientific Practical Center

Sudakov M.A.

European Medical Center

Tarakanov P.V.

Loginov Moscow Clinical Scientific Practical Center

Feoktistova P.S.

Loginov Moscow Clinical Scientific Practical Center

Tsvirkun V.V.

Loginov Moscow Clinical Scientific Practical Center

Zhao A.V.

Sechenov First Moscow State Medical University

Shabunin A.V.

Burnazyan State Scientific Center

Efanov M.G.

Loginov Moscow Clinical Scientific Practical Center

The Russian consensus on the treatment of intrahepatic cholangiocarcinoma

Authors:

Khatkov I.E., Alikhanov R.B., Bedin V.V., Breder V.V., Britskaya N.N., Voskanyan S.E., Vishnevsky V.A., Granov D.A., Zhukova L.G., Zagainov V.E., Kovalenko D.E., Koroleva A.A., Kulezneva Yu.V., Melekhina O.V., Nazarenko A.V., Odintsova M.V., Petrov L.O., Pogrebnyakov I.V., Podluzhny D.V., Polyakov A.N., Porshennikov I.A., Rutkin I.O., Semenov N.N., Sudakov M.A., Tarakanov P.V., Feoktistova P.S., Tsvirkun V.V., Zhao A.V., Shabunin A.V., Efanov M.G.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2024;(10): 7‑20

DOI: 10.17116/hirurgia20241017

Views: 831

Downloaded: 22

Buy for 200₽
Contact the author
Table of contents

To cite this article:

Khatkov IE, Alikhanov RB, Bedin VV, et al. . The Russian consensus on the treatment of intrahepatic cholangiocarcinoma. Pirogov Russian Journal of Surgery. 2024;(10):7‑20. (In Russ.)
https://doi.org/10.17116/hirurgia20241017

Подписка 2025 (Pirogov Russian Journal of Surgery)
МСФ на ЯМ
Close metadata
Recommended articles:
Modern aspe­cts influencing the mana­gement of patients with papi­llary thyroid cancer. Piro­gov Russian Journal of Surgery. 2023;(12):89-94
Complex surgical treatment of recu­rrent post-injection abscess in a patient with systemic autoimmune disease. Piro­gov Russian Journal of Surgery. 2023;(12):123-133
Opti­mal prevention of VTE in cancer surgery patients with impaired renal function. Piro­gov Russian Journal of Surgery. 2024;(1):119-126
Surgical treatment of intracranial aneurysms in acute period of hemo­rrhage in Hunt—Hess grade IV—V patients at Burdenko Neurosurgical Center between 2006 and 2020. Burdenko's Journal of Neurosurgery. 2023;(6):5-13
Cost of drug therapy for treatment and prevention of complications following chro­nic kidney disease during outpatient hemo­dialysis. Medi­cal Technologies. Asse­ssment and Choice. 2023;(4):52-63
The use of modern dressings after complex treatment of mali­gnant tumors of the maxi­llofacial region. Stomatology. 2023;(6-2):61-67
Approaches to the diagnosis and treatment of patients with stage III—IV non-small cell lung cancer in Russia. Preliminary resu­lts of a prospective multicenter non-interventional obse­rvational study KARL. P.A. Herzen Journal of Onco­logy. 2023;(6):33-37
Soli­tary fibrous tumor of the pleura with para­neoplastic Doege-Potter syndrome. P.A. Herzen Journal of Onco­logy. 2023;(6):50-56
Use of Atezolizumab in patients with adva­nced small cell lung cancer. P.A. Herzen Journal of Onco­logy. 2023;(6):63-67
Mastoid osteoma. Russian Bulletin of Otorhinolaryngology. 2023;(6):97-99

The Russian consensus on the treatment of intrahepatic cholangiocarcinoma was prepared by the group of experts consisting of surgeons, interventional radiologists, radiation therapists and oncologists. The purposes of this consensus are clarification and consolidation of opinions of multidisciplinary team on the following issues of management of patients with intrahepatic cholangiocarcinoma: indications for surgical treatment, features of therapeutic tactics for mechanical jaundice, technical aspects of liver resection, prevention of post-resection liver failure, indications for liver resection using transplantation technologies, laparoscopic and robot-assisted liver resection, perioperative systemic chemotherapy, local non-resection/non-radiotherapy methods of treatment, radiotherapy, follow-up and choice of treatment for recurrence.

Keywords:

Russian consensus
Delphic system
intrahepatic cholangiocarcinoma
surgical treatment
liver resection
laparoscopic and robotic liver resection
chemotherapy
radiotherapy
treatment of recurrence

Authors:

Khatkov I.E.

Loginov Moscow Clinical Scientific Practical Center

Alikhanov R.B.

Loginov Moscow Clinical Scientific Practical Center

Bedin V.V.

Burnazyan State Scientific Center

Breder V.V.

Botkin Moscow City Clinical Hospital

Britskaya N.N.

Loginov Moscow Clinical Scientific Practical Center

Voskanyan S.E.

Granov Russian Research Center of Radiology and Surgical Technologies

Vishnevsky V.A.

Vishnevsky National Research Center of Surgery

Granov D.A.

Blokhin National Cancer Research Center

Zhukova L.G.

Loginov Moscow Clinical Scientific Practical Center

Zagainov V.E.

National Medical Research Radiological Center

Kovalenko D.E.

Loginov Moscow Clinical Scientific Practical Center

Koroleva A.A.

Loginov Moscow Clinical Scientific Practical Center

Kulezneva Yu.V.

Loginov Moscow Clinical Scientific Practical Center

Melekhina O.V.

Loginov Moscow Clinical Scientific Practical Center

Nazarenko A.V.

Loginov Moscow Clinical Scientific Practical Center

Odintsova M.V.

Blokhin National Cancer Research Center

Petrov L.O.

Novosibirsk Regional State Hospital

Pogrebnyakov I.V.

Botkin Moscow City Clinical Hospital

Podluzhny D.V.

Botkin Moscow City Clinical Hospital

Polyakov A.N.

Botkin Moscow City Clinical Hospital

Porshennikov I.A.

Nizhny Novgorod Regional Clinical Oncology Dispensary

Rutkin I.O.

Blokhin National Cancer Research Center

Semenov N.N.

Loginov Moscow Clinical Scientific Practical Center

Sudakov M.A.

European Medical Center

Tarakanov P.V.

Loginov Moscow Clinical Scientific Practical Center

Feoktistova P.S.

Loginov Moscow Clinical Scientific Practical Center

Tsvirkun V.V.

Loginov Moscow Clinical Scientific Practical Center

Zhao A.V.

Sechenov First Moscow State Medical University

Shabunin A.V.

Burnazyan State Scientific Center

Efanov M.G.

Loginov Moscow Clinical Scientific Practical Center

Received:

13.05.2024

Accepted:

10.06.2024

List of references:

  1. Kubo S, Shinkawa H, Asaoka Y, Ioka T, Igaki H, Izumi N, Itoi T, Unno M, Ohtsuka M, Okusaka T, Kadoya M, Kudo M, Kumada T, Kokudo N, Sakamoto M, Sakamoto Y, Sakurai H, Takayama T, Nakashima O, Nagata Y, Hatano E, Harada K, Murakami T, Yamamoto M. Liver cancer study sroup of Japan clinical practice guidelines for intrahepatic cholangiocarcinoma. Liver Cancer. 2022;11(4):290-314.  https://doi.org/10.1159/000522403
  2. Luo S, Wu L, Li M, Wang J, Wang C, Yang J, Zhang L, Ge J, Sun C, Li E, Lei J, Zhou F, Liao W. Validation of the prognostic role for surgical treatment in stage II intrahepatic cholangiocarcinoma: a SEER population-based study. Journal of Clinical Medicine. 2023;12(2):675.  https://doi.org/10.3390/jcm12020675
  3. Franssen S, Soares KC, Jolissaint JS, Tsilimigras DI, Buettner S, Alexandrescu S, Marques H, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Margonis GA, Weiss MJ, Bauer TW, Shen F, Poultsides GA, Marsh JW, Cercek A, Kemeny N, Kingham TP, D’Angelica M, Pawlik TM, Jarnagin WR, Koerkamp BG. Comparison of hepatic arterial infusion pump chemotherapy vs resection for patients with multifocal intrahepatic cholangiocarcinoma. JAMA Surgery. 2022;157(7):590-596.  https://doi.org/10.1001/jamasurg.2022.1298
  4. Rushbrook SM, Kendall TJ, Zen Y, Albazaz R, Manoharan P, Pereira SP, Sturgess R, Davidson BR, Malik HZ, Manas D, Heaton N, Prasad KR, Bridgewater J, Valle JW, Goody R, Hawkins M, Prentice W, Morement H, Walmsley M, Khan SA. British society of gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma. Gut. 2023;73(1):16-46.  https://doi.org/10.1136/gutjnl-2023-330029
  5. Benson AB, D’Angelica MI, Abbott DE, Abrams TA, Alberts SR, Saenz DA, Are C, Brown DB, Chang DT, Covey AM, Hawkins W, Iyer R, Jacob R, Karachristos A, Kelley R., Kim R, Palta M, Park JO, Sahai V, Schefter T, Schmidt C, Sicklick JK, Singh G, Sohal D, Stein S, Tian GG, Vauthey JN, Venook AP, Zhu AX, Hoffmann KG, Darlow S. NCCN guidelines insights: hepatobiliary cancers, version 1.2017. Journal of the National Comprehensive Cancer Network. 2017;15(5):563-573.  https://doi.org/10.6004/jnccn.2017.0059
  6. Linstone H, Turoff M. The Delphi method: Techniques and applications. Massachusetts: Addison-Wesley; 1975.
  7. Wu Y, Xia C, Chen J, Qin Q, Ye Z, Song B. Diagnostic performance of magnetic resonance imaging and contrast-enhanced ultrasound in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma: a meta-analysis. Abdominal Radiology. 2024;49(1):34-48.  https://doi.org/10.1007/s00261-023-04064-z
  8. Cerrito L, Ainora ME, Borriello R, Piccirilli G, Garcovich M, Riccardi L, Pompili M, Gasbarrini A, Zocco MA. Contrast-Enhanced Imaging in the Management of Intrahepatic Cholangiocarcinoma: State of Art and Future Perspectives. Cancers. 2023;15(13):3393. https://doi.org/10.3390/cancers15133393
  9. Honda T, Onishi H, Fukui H, Yano K, Kiso K, Nakamoto A, Tsuboyama T, Ota T, Tatsumi M, Tahara S, Kobayashi S, Eguchi H, Tomiyama N. Extracellular volume fraction using contrast-enhanced CT is useful in differentiating intrahepatic cholangiocellular carcinoma from hepatocellular carcinoma. Frontiers in Oncology. 2023;13:1214977. https://doi.org/10.3389/fonc.2023.1214977
  10. Lubner MG, Larison WG, Watson R, Wells SA, Ziemlewicz TJ, Lubner SJ, Pickhardt PJ. Efficacy of percutaneous image-guided biopsy for diagnosis of intrahepatic cholangiocarcinoma. Abdominal Radiology. 2022;47(8):2647-2657. https://doi.org/10.1007/s00261-021-03278-3
  11. Al Bulushi Y, Cruz-Romero C, Kavandi H, Brook A, Brook OR. Predicting successful ultrasound-guided biopsy of liver lesions. Abdominal Radiology. 2023;48(11):3498-3505. https://doi.org/10.1007/s00261-023-04017-6
  12. Ribero D, Pinna AD, Guglielmi A, Ponti A, Nuzzo G, Giulini SM, Aldrighetti L, Calise F, Gerunda GE, Tomatis M, Amisano M, Berloco P, Torzilli G, Capussotti L; Italian Intrahepatic Cholangiocarcinoma Study Group. Surgical Approach for Long-term Survival of Patients With Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 434 Patients. The Archives of Surgery. 2012;147(12):1107-1113. https://doi.org/10.1001/archsurg.2012.1962
  13. Weber SM, Ribero D, O’Reilly EM, Kokudo N, Miyazaki M, Pawlik TM. Intrahepatic cholangiocarcinoma: expert consensus statement. HPB. 2015;17(8):669-680.  https://doi.org/10.1111/hpb.12441
  14. Jansson H, Villard C, Nooijen LE, Ghorbani P, Erdmann JI, Sparrelid E. Prognostic influence of multiple hepatic lesions in resectable intrahepatic cholangiocarcinoma: A systematic review and meta-analysis. European Journal of Surgical Oncology. 2023;49(4):688-699.  https://doi.org/10.1016/j.ejso.2023.01.006
  15. Conci S, Ruzzenente A, Viganò L, Ercolani G, Fontana A, Bagante F, Bertuzzo F, Dore A, Pinna AD, Torzilli G, Iacono C, Guglielmi A. Patterns of Distribution of Hepatic Nodules (Single, Satellites or Multifocal) in Intrahepatic Cholangiocarcinoma: Prognostic Impact After Surgery. Annals of Surgical Oncology. 2018;25(12):3719-3727. https://doi.org/10.1245/s10434-018-6669-1
  16. Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis. JAMA Surgery. 2014;149(6):565-574.  https://doi.org/10.1001/jamasurg.2013.5137
  17. Lamarca A, Santos-Laso A, Utpatel K, La Casta A, Stock S, Forner A, Adeva J, Folseraas T, Fabris L, Macias RIR, Krawczyk M, Krawczyk M, Cardinale V, Braconi C, Alvaro D, Evert M, Banales JM, Valle JW; Group: on behalf of the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System. Hepatology. 2021;73(6):2311-2325. https://doi.org/10.1002/hep.31598
  18. Buettner S, Ten Cate DWG, Bagante F, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Margonis GA, Weiss M, Bauer TW, Shen F, Poultsides GA, Marsh JW, IJzermans JNM, Pawlik TM, Koerkamp BG. Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma. Journal of Gastrointestinal Surgery. 2019;23(11):2239-2246. https://doi.org/10.1007/s11605-019-04184-2
  19. Yang R, Wang B, Chen YJ, Li HB, Hu JB, Zou SQ. Efficacy of gemcitabine plus platinum agents for biliary tract cancers: a meta-analysis. Anticancer Drugs. 2013;24(8):871-877.  https://doi.org/10.1097/CAD.0b013e3283637292
  20. Sutton TL, Billingsley KG, Walker BS, Fung AW, Maynard E, Enestvedt CK, Dewey EN, Brinkerhoff BT, Lopez CD, Orloff SL, Mayo SC. Detection of Tumor Multifocality in Resectable Intrahepatic Cholangiocarcinoma: Defining the Optimal Pre-operative Imaging Modality. Journal of Gastrointestinal Surgery. 2021;25(9):2250-2257. https://doi.org/10.1007/s11605-021-04911-8
  21. Jansson H, Villard C, Nooijen LE, Ghorbani P, Erdmann JI, Sparrelid E. Prognostic influence of multiple hepatic lesions in resectable intrahepatic cholangiocarcinoma: A systematic review and meta-analysis. European Journal of Surgical Oncology. 2023;49(4):688-699.  https://doi.org/10.1016/j.ejso.2023.01.006
  22. Addeo P, Jedidi I, Locicero A, Faitot F, Oncioiu C, Onea A, Bachellier P. Prognostic Impact of Tumor Multinodularity in Intrahepatic Cholangiocarcinoma. Journal of Gastrointestinal Surgery. 2019;23(9):1801-1809. https://doi.org/10.1007/s11605-018-4052-y
  23. Kong J, Cao Y, Chai J, Liu X, Lin C, Wang J, Liu J. Effect of Tumor Size on Long-Term Survival After Resection for Solitary Intrahepatic Cholangiocarcinoma. Frontiers in Oncology. 2021;21;10:559911. https://doi.org/10.3389/fonc.2020.559911
  24. Spolverato G, Ejaz A, Kim Y, Sotiropoulos GC, Pau A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Clary BM, Aldrighetti L, Bauer TW, Walters DM, Groeschl R, Gamblin TC, Marsh W, Nguyen KT, Turley R, Popescu I, Hubert C, Meyer S, Gigot JF, Mentha G, Pawlik TM. Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma. Journal of Gastrointestinal Surgery. 2014;18(7):1284-1291. https://doi.org/10.1007/s11605-014-2533-1
  25. Mabilia A, Mazzotta AD, Robin F, Ghallab M, Vibert E, Adam R, Cherqui D, Cunha AS, Azoulay D, Salloum C, Pittau G, Ciacio O, Allard MA, Boudjema K, Sulpice L, Golse N. R1 Vascular or Parenchymal Margins: What Is the Impact after Resection of Intrahepatic Cholangiocarcinoma? Cancers. 2022;14(20):5151. https://doi.org/10.3390/cancers14205151
  26. Conci S, Viganò L, Ercolani G, Gonzalez E, Ruzzenente A, Isa G, Salaris C, Fontana A, Bagante F, Pedrazzani C, Campagnaro T, Iacono C, De Santibanes E, Pinna DA, Torzilli G, Guglielmi A. Outcomes of vascular resection associated with curative intent hepatectomy for intrahepatic cholangiocarcinoma. European Journal of Surgical Oncology. 2020;46(9):1727-1733. https://doi.org/10.1016/j.ejso.2020.04.007
  27. Reese T, Pagel G, Bause BA, von Rittberg Y, Wagner KC, Oldhafer KJ. Complex Liver Resections for Intrahepatic Cholangiocarcinoma. Journal of Clinical Medicine. 2021;10(8):1672. https://doi.org/10.3390/jcm10081672
  28. Ali SM, Clark CJ, Zaydfudim VM, Que FG, Nagorney DM. Role of major vascular resection in patients with intrahepatic cholangiocarcinoma. Annals of Surgical Oncology. 2013;20(6):2023-2028. https://doi.org/10.1245/s10434-012-2808-2
  29. Palen A, Garnier J, Hobeika C, Ewald J, Gregoire E, Delpero JR, Le Treut YP, Turrini O, Hardwigsen J. Oncological relevance of major hepatectomy with inferior vena cava resection for intrahepatic cholangiocarcinoma. HPB. 2021;23(9):1439-1447. https://doi.org/10.1016/j.hpb.2021.02.007
  30. Liu H, Lin L, Lin Z, Chen Y, Huang Q, Ding L, Lou J, Zheng S, Bi X, Wang J, Guo W, Li F, Wang J, Zheng Y, Li J, Cheng S, Zhou W, Cheng Z, Zeng Y. Impact of surgical margin width on long-term outcomes for intrahepatic cholangiocarcinoma: a multicenter study. BMC Cancer. 2021;21(1):840.  https://doi.org/10.1186/s12885-021-08560-7
  31. Ali SM, Clark CJ, Zaydfudim VM, Que FG, Nagorney DM. Role of major vascular resection in patients with intrahepatic cholangiocarcinoma. Annals of Surgical Oncology. 2013;20(6):2023-2028. https://doi.org/10.1245/s10434-012-2808-2
  32. Bartsch F, Baumgart J, Hoppe-Lotichius M, Straub BK, Heinrich S, Lang H. Intrahepatic cholangiocarcinoma — influence of resection margin and tumor distance to the liver capsule on survival. BMC Surgery. 2020;20(1):61.  https://doi.org/10.1186/s12893-020-00718-7
  33. Zhang XF, Bagante F, Chakedis J, Moris D, Beal EW, Weiss M, Popescu I, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Groot Koerkamp B, Guglielmi A, Itaru E, Pawlik TM. Perioperative and long-term outcome of intrahepatic cholangiocarcinoma involving the hepatic hilus after curative-intent resection: comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma. Journal of Gastrointestinal Surgery. 2017;21(11):1841-1850. https://doi.org/10.1007/s11605-017-3499-6
  34. Mansour JC, Aloia TA, Crane CH, Heimbach JK, Nagino M, Vauthey JN. Hilar Cholangiocarcinoma: expert consensus statement. HPB. 2015;17(8):691-699.  https://doi.org/10.1111/hpb.12450
  35. Kennedy TJ, Yopp A, Qin Y, Zhao B, Guo P, Liu F, Schwartz LH, Allen P, D’Angelica M, Fong Y, DeMatteo RP, Blumgart LH, Jarnagin WR. Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB. 2009;11(5):445-451.  https://doi.org/10.1111/j.1477-2574.2009.00090.x
  36. Nagino M. Perihilar cholangiocarcinoma: a surgeon’s viewpoint on current topics. Journal of Gastroenterology. 2012;47(11):1165-1176. https://doi.org/10.1007/s00535-012-0628-6
  37. Iacono C, Ruzzenente A, Campagnaro T, Bortolasi L, Valdegamberi A, Guglielmi A. Role of preoperative biliary drainage in jaundiced patients who are candidates for pancreatoduodenectomy or hepatic resection: highlights and drawbacks. Annals of Surgery. 2013;257(2):191-204.  https://doi.org/10.1097/SLA.0b013e31826f4b0e
  38. Paik WH, Loganathan N, Hwang JH. Preoperative biliary drainage in hilar cholangiocarcinoma: When and how? World Journal of Gastrointestinal Endoscopy. 2014;6(3):68-73.  https://doi.org/10.4253/wjge.v6.i3.68
  39. Lang H, Baumgart J, Heinrich S, Huber T, Heuft LK, Margies R, Mittler J, Hahn F, Gerber TS, Foerster F, Weinmann A, Marquardt JU, Kloeckner R, Straub BK, Bartsch F. Liver Resection for Intrahepatic Cholangiocarcinoma — Single-Center Experience with 286 Patients Undergoing Surgical Exploration over a Thirteen Year Period. Journal of Clinical Medicine. 2021;10(16):3559. https://doi.org/10.3390/jcm10163559
  40. Zhang XF, Bagante F, Chakedis J, Moris D, Beal EW, Weiss M, Popescu I, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Groot Koerkamp B, Guglielmi A, Itaru E, Pawlik TM. Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy. Journal of Gastrointestinal Surgery. 2017;21(11):1841-1850. https://doi.org/10.1007/s11605-017-3499-6
  41. Kinoshita M, Kanazawa A, Takemura S, Tanaka S, Kodai S, Shinkawa H, Shimizu S, Murata A, Nishio K, Hamano G, Ito T, Tsukamoto T, Kubo S. Indications for laparoscopic liver resection of mass-forming intrahepatic cholangiocarcinoma. Asian Journal of Endoscopic Surgery. 2020;13(1):46-58.  https://doi.org/10.1111/ases.12703
  42. Si A, Li J, Yang Z, Xia Y, Yang T, Lei Z, Cheng Z, Pawlik TM, Lau WY, Shen F. Impact of Anatomical Versus Non-anatomical Liver Resection on Short- and Long-Term Outcomes for Patients with Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology. 2019;26(6):1841-1850. https://doi.org/10.1245/s10434-019-07260-8
  43. Mabilia A, Mazzotta AD, Robin F, Ghallab M, Vibert E, Adam R, Cherqui D, Cunha AS, Azoulay D, Salloum C, Pittau G, Ciacio O, Allard MA, Boudjema K, Sulpice L, Golse N. R1 Vascular or Parenchymal Margins: What Is the Impact after Resection of Intrahepatic Cholangiocarcinoma? Cancers. 2022;14(20):5151. https://doi.org/10.3390/cancers14205151
  44. Li MX, Bi XY, Li ZY, Huang Z, Han Y, Zhao JJ, Zhao H, Cai JQ. Impaction of surgical margin status on the survival outcome after surgical resection of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis. Journal of Surgical Research. 2016;203(1):163-173.  https://doi.org/10.1016/j.jss.2016.02.012
  45. Alikhanov R, Dudareva A, Trigo MÁ, Serrablo A. Vascular Resection for Intrahepatic Cholangiocarcinoma: Current Considerations. Journal of Clinical Medicine. 2021;10(17):3829. https://doi.org/10.3390/jcm10173829
  46. Zhu H, Wang L, Wang M, He X, Xu W, Zhu W, Zhao Y, Wang L. Prognostic value of resection margin length after surgical resection for intrahepatic cholangiocarcinoma. American Journal of Surgery. 2021;222(2):383-389.  https://doi.org/10.1016/j.amjsurg.2020.12.022
  47. Kang CM, Suh KS, Yi NJ, Hong TH, Park SJ, Ahn KS, Hayashi H, Choi SB, Jeong CY, Takahara T, Shiozaki S, Roh YH, Yu HC, Fukumoto T, Matsuyama R, Naoki U, Hashida K, Seo HI, Okabayashi T, Kitajima T, Satoi S, Nagano H, Kim H, Taira K, Kubo S, Choi DW. Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea-Japan Study. Cancers. 2021;13(3):445.  https://doi.org/10.3390/cancers13030445
  48. Shimada K, Sano T, Nara S, Esaki M, Sakamoto Y, Kosuge T, Ojima H. Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. Surgery. 2009;145(4):411-416.  https://doi.org/10.1016/j.surg.2008.11.010
  49. Zhang XF, Xue F, Dong DH, Weiss M, Popescu I, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Koerkamp BG, Itaru E, Lv Y, Pawlik TM. Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact Prognosis. Annals of Surgery. 2021;274(6):e1187-e1195. https://doi.org/10.1097/SLA.0000000000003788
  50. Wang J, Shu M, Peng H, Li S, Li D, Shen J, Kuang M, Zhang Y, Chen Z. The influence of the extent of lymph node metastasis on the prognosis for patients with intrahepatic cholangiocarcinoma. Annals of Surgical Treatment and Research. 2023;104(5):258-268.  https://doi.org/10.4174/astr.2023.104.5.258
  51. Sposito C, Ratti F, Cucchetti A, Ardito F, Ruzzenente A, Di Sandro S, Maspero M, Ercolani G, Di Benedetto F, Guglielmi A, Giuliante F, Aldrighetti L, Mazzaferro V. Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma. Journal of Hepatology. 2023;78(2):356-363.  https://doi.org/10.1016/j.jhep.2022.10.021
  52. Beal EW, Cloyd JM, Pawlik TM. Surgical Treatment of Intrahepatic Cholangiocarcinoma: Current and Emerging Principles. Journal of Clinical Medicine. 2020;10(1):104.  https://doi.org/10.3390/jcm10010104
  53. Li J, Moustafa M, Linecker M, Lurje G, Capobianco I, Baumgart J, Ratti F, Rauchfuss F, Balci D, Fernandes E, Montalti R, Robles-Campos R, Bjornsson B, Topp SA, Fronek J, Liu C, Wahba R, Bruns C, Brunner SM, Schlitt HJ, Heumann A, Stüben BO, Izbicki JR, Bednarsch J, Gringeri E, Fasolo E, Rolinger J, Kristek J, Hernandez-Alejandro R, Schnitzbauer A, Nuessler N, Schön MR, Voskanyan S, Petrou AS, Hahn O, Soejima Y, Vicente E, Castro-Benitez C, Adam R, Tomassini F, Troisi RI, Kantas A, Oldhafer KJ, Ardiles V, de Santibanes E, Malago M, Clavien PA, Vivarelli M, Settmacher U, Aldrighetti L, Neumann U, Petrowsky H, Cillo U, Lang H, Nadalin S. ALPPS for Locally Advanced Intrahepatic Cholangiocarcinoma: Did Aggressive Surgery Lead to the Oncological Benefit? An International Multi-center Study. Annals of Surgical Oncology. 2020;27(5):1372-1384. https://doi.org/10.1245/s10434-019-08192-z
  54. Kim D, Cornman-Homonoff J, Madoff DC. Preparing for liver surgery with «Alphabet Soup»: PVE, ALPPS, TAE-PVE, LVD and RL. Hepatobiliary Surg Nutr. 2020;9(2):136-151.  https://doi.org/10.21037/hbsn.2019.09.10
  55. Kishi Y, Vauthey JN. Issues to be considered to address the future liver remnant prior to major hepatectomy. Surgery Today. 2021;51(4):472-484.  https://doi.org/10.1007/s00595-020-02088-2
  56. Primavesi F, Maglione M, Cipriani F, Denecke T, Oberkofler CE, Starlinger P, Dasari BVM, Heil J, Sgarbura O, Søreide K, Diaz-Nieto R, Fondevila C, Frampton AE, Geisel D, Henninger B, Hessheimer AJ, Lesurtel M, Mole D, Öllinger R, Olthof P, Reiberger T, Schnitzbauer AA, Schwarz C, Sparrelid E, Stockmann M, Truant S, Aldrighetti L, Braunwarth E, D’Hondt M, DeOliveira ML, Erdmann J, Fuks D, Gruenberger T, Kaczirek K, Malik H, Öfner D, Rahbari NN, Göbel G, Siriwardena AK, Stättner S. E-AHPBA-ESSO-ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomy. British Journal of Surgery. 2023;110(10):1331-1347. https://doi.org/10.1093/bjs/znad233
  57. van Lienden KP, van den Esschert JW, de Graaf W, Bipat S, Lameris JS, van Gulik TM, van Delden OM. Portal vein embolization before liver resection: a systematic review. CardioVascular and Interventional Radiology. 2013;36(1):25-34.  https://doi.org/10.1007/s00270-012-0440-y
  58. Glantzounis GK, Tokidis E, Basourakos SP, Ntzani EE, Lianos GD, Pentheroudakis G. The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review. European Journal of Surgical Oncology. 2017;43(1):32-41.  https://doi.org/10.1016/j.ejso.2016.05.026
  59. Böning G, Fehrenbach U, Auer TA, Neumann K, Jonczyk M, Pratschke J, Schöning W, Schmelzle M, Gebauer B. Liver Venous Deprivation (LVD) Versus Portal Vein Embolization (PVE) Alone Prior to Extended Hepatectomy: A Matched Pair Analysis. CardioVascular and Interventional Radiology. 2022;45(7):950-957.  https://doi.org/10.1007/s00270-022-03107-0
  60. Chebaro A, Buc E, Durin T, Chiche L, Brustia R, Didier A, Pruvot FR, Kitano Y, Muscari F, Lecolle K, Sulpice L, Sonmez E, Bougard M, El Amrani M, Sommacale D, Maulat C, Ayav A, Adam R, Laurent C, Truant S. Liver Venous Deprivation or Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy?: A Retrospective Multicentric Study. Annals of Surgery. 2021;274(5):874-880.  https://doi.org/10.1097/SLA.0000000000005121
  61. Olthof PB, Coelen RJS, Wiggers JK, Groot Koerkamp B, Malago M, Hernandez-Alejandro R, Topp SA, Vivarelli M, Aldrighetti LA, Robles Campos R, Oldhafer KJ, Jarnagin WR, van Gulik TM. High mortality after ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international ALPPS registry. HPB. 2017;19(5):381-387.  https://doi.org/10.1016/j.hpb.2016.10.008
  62. Balci D, Kirimker EO, Üstüner E, Yilmaz AA, Azap A. Stage I-laparoscopy partial ALPPS procedure for perihilar cholangiocarcinoma. Journal of Surgical Oncology. 2020;121(6):1022-1026. https://doi.org/10.1002/jso.25868
  63. Ribero D, Amisano M, Bertuzzo F, Langella S, Lo Tesoriere R, Ferrero A, Regge D, Capussotti L. Measured versus Estimated Total Liver Volume to Preoperatively Assess the Adequacy of the Future Liver Remnant Which Method Should We Use? Annals of Surgery. 2013;258(5):801-806.  https://doi.org/10.1097/SLA.0000000000000213
  64. Schwarz C, Plass I, Fitschek F, Punzengruber A, Mittlböck M, Kampf S, Asenbaum U, Starlinger P, Stremitzer S, Bodingbauer M, Kaczirek K. The value of indocyanine green clearance assessment to predict postoperative liver dysfunction in patients undergoing liver resection. Scientific Reports. 2019;9(1):8421. https://doi.org/10.1038/s41598-019-44815-x
  65. Stockmann M, Lock JF, Malinowski M, Niehues SM, Seehofer D, Neuhaus P. The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB. 2010;12(2):139-146.  https://doi.org/10.1111/j.1477-2574.2009.00151.x
  66. Shorikov MA, Sergeeva ON, Kashkadaeva AV, Averinova SG, Lapteva MG, Francev DYu, Polyakov AN, Kudashkin NE, Alexin AP, Moroz EA, Virshke E`R, Dolgushin BI. Functional assessment of the liver in patients with bile duct diseases using gadoxetic acid compared with the “gold standard” — hepatobiliscintigraphy. Vestnik rentgenologii i radiologii. 2019;100(4):200-208. (In Russ.). https://doi.org/10.20862/0042-4676-2019-100-4-200-208
  67. Feng ST, Wu L, Cai H, Chan T, Luo Y, Dong Z, Zheng K, Li ZP. Cholangiocarcinoma: spectrum of appearances on Gd-EOB-DTPA-enhanced MR imaging and the effect of biliary function on signal intensity. BMC Cancer. 2015;15:38.  https://doi.org/10.1186/s12885-015-1039-x
  68. Serenari M, Collaud C, Alvarez FA, de Santibañes M, Giunta D, Pekolj J, Ardiles V, de Santibañes E. Interstage assessment of remnant liver function in ALPPS using hepatobiliary scintigraphy: prediction of posthepatectomy liver failure and introduction of the HIBA index. Annals of Surgery. 2018;267(6):1141-1147. https://doi.org/10.1097/SLA.0000000000002150
  69. Balci D, Sakamoto Y, Li J, Di Benedetto F, Kirimker EO, Petrowsky H. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) procedure for cholangiocarcinoma. International Journal of Surgery. 2020;82S:97-102.  https://doi.org/10.1016/j.ijsu.2020.06.045
  70. Kim PP, Bondar` LV, Alixanov RB, Efanova MG, Starostina NS, Melexina OV, Kulezneva YuV. Comparative analysis of static scintigraphy and computed tomography in assessing the volume of residual parenchyma in extensive liver lesions. Pirogov Russian Journal of Surgery. 2017;(5):23-26. (In Russ.). https://doi.org/10.17116/hirurgia2017523-26
  71. Efanov MG, Alixanov RB, Vishnevskij VA. Transplantation technologies in resection surgery of locally common liver tumors. Annaly` chirurgicheskoj gepatologii. 2018;23(4):11-20. (In Russ.). https://doi.org/10.16931/1995-5464.2018411-20
  72. Shen S, Kong J, Qiu Y, Zhang S, Qin Y, Wang W. Ex vivo liver resection and autotransplantation versus allotransplantation for end-stage hepatic alveolar echinococcosis. International Journal of Infectious Diseases. 2019;79:87-93.  https://doi.org/10.1016/j.ijid.2018.11.016
  73. Zagajnov VE, Porshennikov IA, Kiselev NM, Najdenov EV, Pavlik VN, Voskanyan SE. A new classification as the basis for changing approaches to surgical treatment of liver alveococcosis. The results of the work of the three centers. Annaly` chirurgicheskoj gepatologii. 2020;25(4):20-32. (In Russ.). https://doi.org/10.16931/1995-5464.2020420-32
  74. Zawistowski M, Nowaczyk J, Jakubczyk M, Domagała P. Outcomes of ex vivo liver resection and autotransplantation: A systematic review and meta-analysis. Surgery. 2020;168(4):631-642.  https://doi.org/10.1016/j.surg.2020.05.036
  75. Zhao X, Gao FW, Jiang KY, Yang J, Xie QY, Gong J, Yang MY, Mao TY, Lei ZH. Laparoscopic or open liver resection for intrahepatic cholangiocarcinoma: A meta-analysis and systematic review. Frontiers in Oncology. 2023;13:1096714. https://doi.org/10.3389/fonc.2023.1096714
  76. Ratti F, Rawashdeh A, Cipriani F, Primrose J, Fiorentini G, Abu Hilal M, Aldrighetti L. Intrahepatic cholangiocarcinoma as the new field of implementation of laparoscopic liver resection programs. A comparative propensity score-based analysis of open and laparoscopic liver resections. Surgical Endoscopy. 2021;35(4):1851-1862. https://doi.org/10.1007/s00464-020-07588-3
  77. Hu YF, Hu HJ, Ma WJ, Jin YW, Li FY. Laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma: a systematic review of propensity score-matched studies. Updates in Surgery. 2023;75(8):2049-2061. https://doi.org/10.1007/s13304-023-01648-8
  78. Li HJ, Wang Q, Yang ZL, Zhu FF, Xiang ZQ, Long ZT, Dai XM, Zhu Z. Laparoscopic versus open hepatectomy for intrahepatic cholangiocarcinoma: Systematic review and meta-analysis of propensity score-matched studies. European Journal of Surgical Oncology. 2023;49(4):700-708.  https://doi.org/10.1016/j.ejso.2023.02.010
  79. Sahakyan MA, Aghayan DL, Edwin B, Alikhanov R, Britskaia N, Brudvik KW, D’Hondt M, De Meyere C, Efanov M, Fretland ÅA, Hoff R, Ismail W, Ivanecz A, Kazaryan AM, Lassen K, Magdalenić T, Parmentier I, Røsok BI, Villanger O, Yaqub S. Laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma: a multicenter propensity score-matched study. Scandinavian Journal of Gastroenterology. 2023;58(5):489-496.  https://doi.org/10.1080/00365521.2022.2143724
  80. Liu R, Wakabayashi G, Kim HJ, Choi GH, Yiengpruksawan A, Fong Y, He J, Boggi U, Troisi RI, Efanov M, Azoulay D, Panaro F, Pessaux P, Wang XY, Zhu JY, Zhang SG, Sun CD, Wu Z, Tao KS, Yang KH, Fan J, Chen XP. International consensus statement on robotic hepatectomy surgery in 2018. World Journal of Gastroenterology. 2019;25(12):1432-1444. https://doi.org/10.3748/wjg.v25.i12.1432
  81. Efanov MG, Alichanov RB, Kazakov IV, Van`kovich AN, Melechina OV, Kulezneva YuV, Elizarova NI, Koroleva AA, Kovalenko DE, Tzvirkun VV. Robot-assisted and open resections of the liver and bile ducts in portal cholangiocarcinoma. A comparative analysis of the immediate results. Annaly` chirurgicheskoj gepatologii. 2020;25(4):60-70. (In Russ.). https://doi.org/10.16931/1995-5464.2020460-70
  82. Chiow AK, Fuks D, Choi GH, Syn N, Sucandy I, Marino MV, Prieto M, Chong CC, Lee JH, Efanov M, Kingham TP, Choi SH, Sutcliffe RP, Troisi RI, Pratschke J, Cheung TT, Wang X, Liu R, D’Hondt M, Chan CY, Tang CN, Han HS, Goh BKP. International Robotic and Laparoscopic Liver Resection Study Group collaborators. International multicentre propensity score-matched analysis comparing robotic versus laparoscopic right posterior sectionectomy. British Journal of Surgery. 2021;108(12):1513-1520. https://doi.org/10.1093/bjs/znab321
  83. Yang HY, Choi GH, Chin KM, Choi SH, Syn NL, Cheung TT, Chiow AKH, Sucandy I, Marino MV, Prieto M, Chong CC, Lee JH, Efanov M, Kingham TP, Sutcliffe RP, Troisi RI, Pratschke J, Wang X, D’Hondt M, Tang CN, Liu R, Park JO, Rotellar F, Scatton O, Sugioka A, Long TCD, Chan CY, Fuks D, Han HS, Goh BKP. the International Robotic and Laparoscopic Liver Resection Study Group Investigators. Robotic and laparoscopic right anterior sectionectomy and central hepatectomy: multicentre propensity score-matched analysis. British Journal of Surgery. 2022;109(4):311-314.  https://doi.org/10.1093/bjs/znab463
  84. Chong CCN, Lok HT, Fung AKY, Fong AK, Cheung YS, Wong J, Lee KF, Lai PBS. Robotic versus laparoscopic hepatectomy: application of the difficulty scoring system. Surgical Endoscopy. 2020;34(5):2000-2006. https://doi.org/10.1007/s00464-019-06976-8
  85. Efanov M, Alikhanov R, Tsvirkun V, Kazakov I, Melekhina O, Kim P, Vankovich A, Grendal K, Berelavichus S, Khatkov I. Comparative analysis of learning curve in complex robot-assisted and laparoscopic liver resection. HPB. 2017;19(9):818-824.  https://doi.org/10.1016/j.hpb.2017.05.003
  86. Kamarajah SK, Bundred J, Manas D, Jiao L, Hilal MA, White SA. Robotic versus conventional laparoscopic liver resections: A systematic review and meta-analysis. Scandinavian Journal of Surgery. 2021;110(3):290-300.  https://doi.org/10.1177/1457496920925637
  87. Spampinato MG, Coratti A, Bianco L, Caniglia F, Laurenzi A, Puleo F, Ettorre GM, Boggi U. Perioperative outcomes of laparoscopic and robot-assisted major hepatectomies: an Italian multi-institutional comparative study. Surgical Endoscopy. 2014;28(10):2973-2979. https://doi.org/10.1007/s00464-014-3560-4
  88. Sucandy I, Luberice K, Lippert T, Castro M, Krill E, Ross S, Rosemurgy A. Robotic Major Hepatectomy: An Institutional Experience and Clinical Outcomes. Annals of Surgical Oncology. 2020;27(13):4970-4979. https://doi.org/10.1245/s10434-020-08845-4
  89. Magistri P, Assirati G, Ballarin R, Di Sandro S, Di Benedetto F. Major robotic hepatectomies: technical considerations. Updates in Surgery. 2021;73(3):989-997.  https://doi.org/10.1007/s13304-020-00940-1
  90. Efanov MG, Britskaya NN, Tarakanov PV, Koroleva AA, Van`kovich AN, Kovalenko DE, Tzvirkun VV. Robot-assisted liver resection for locally advanced intrahepatic cholangiocarcinoma. Annaly` chirurgicheskoj gepatologii. 2023;28(4):61-70. (In Russ.). https://doi.org/10.16931//1995-5464.2023-4-61-70
  91. Kim GH, Kim PH, Kim JH, Kim PN, Won HJ, Shin YM, Choi SH. Thermal ablation in the treatment of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis. European Radiology. 2022;32(2):1205-1215. https://doi.org/10.1007/s00330-021-08216-x
  92. Zhang K, Yu J, Yu X, Han Z, Cheng Z, Liu F, Liang P. Clinical and survival outcomes of percutaneous microwave ablation for intrahepatic cholangiocarcinoma. International Journal of Hyperthermia. 2018;34(3):292-297.  https://doi.org/10.1080/02656736.2017.1327678
  93. Xu C, Li L, Xu W, Du C, Yang L, Tong J, Yi Y. Ultrasound-guided percutaneous microwave ablation versus surgical resection for recurrent intrahepatic cholangiocarcinoma: intermediateterm results. International Journal of Hyperthermia. 2019;36(1):351-358.  https://doi.org/10.1080/02656736.2019.1571247
  94. Smart AC, Goyal L, Horick N, Petkovska N, Zhu AX, Ferrone CR, Tanabe KK, Allen JN, Drapek LC, Qadan M, Murphy JE, Eyler CE, Ryan DP, Hong TS, Wo JY. Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology. 2020;27(4):1122-1129. https://doi.org/10.1245/s10434-019-08142-9
  95. Jonczyk M, Collettini F, Schnapauff D, Geisel D, Böning G, Feldhaus F, Denecke T, Wieners G, Hamm B, Gebauer B. Cholangiocarcinoma: CT-guided High-Dose Rate Brachytherapy (CT-HDRBT) for Limited (<4 cm) and Large (>4 cm) Tumors. Anticancer Research. 2018;38(10):5843-5852. https://doi.org/10.21873/anticanres.12926
  96. Kojima T, Umeda Y, Fuji T, Niguma T, Sato D, Endo Y, Sui K, Inagaki M, Oishi M, Ota T, Hioki K, Matsuda T, Aoki H, Hirai R, Kimura M, Yagi T, Fujiwara T. Efficacy of surgical management for recurrent intrahepatic cholangiocarcinoma: A multi-institutional study by the Okayama Study Group of HBP surgery. PLoS One. 2020;15(9):e0238392. https://doi.org/10.1371/journal.pone.0238392
  97. Wang C, Pang S, Si-Ma H, Yang N, Zhang H, Fu Y, Yang G. Specific risk factors contributing to early and late recurrences of intrahepatic cholangiocarcinoma after curative resection. World Journal of Surgical Oncology. 2019;17(1):2.  https://doi.org/10.1186/s12957-018-1540-1
  98. Yoo T, Park SJ, Han SS, Kim SH, Lee SD, Kim YK, Kim TH, Woo SM, Lee WJ, Hong EK. Postoperative CA19-9 Change Is a Useful Predictor of Intrahepatic Cholangiocarcinoma Survival following Liver Resection. Disease Markers. 2015;2015:298985. https://doi.org/10.1155/2015/298985
  99. Li H, Feng Y, Liu C, Li J, Li J, Wu H, Wang G, Li D. Importance of Normalization of Carbohydrate Antigen 19-9 in Patients With Intrahepatic Cholangiocarcinoma. Frontiers in Oncology. 2021;11:780455. https://doi.org/10.3389/fonc.2021.780455
  100. Choi WJ, Williams PJ, Claasen MPAW, Ivanics T, Englesakis M, Gallinger S, Hansen B, Sapisochin G. Systematic Review and Meta-Analysis of Prognostic Factors for Early Recurrence in Intrahepatic Cholangiocarcinoma After Curative-Intent Resection. Annals of Surgical Oncology. 2022;29(4):4337-4353. https://doi.org/10.1245/s10434-022-11463-x
  101. Nassar A, Tzedakis S, Sindayigaya R, Hobeika C, Marchese U, Veziant J, Codjia T, Beaufrère A, Dhote A, Strigalev M, Cauchy F, Fuks D. Factors of Early Recurrence After Resection for Intrahepatic Cholangiocarcinoma. World Journal of Surgery. 2022;46(10):2459-2467. https://doi.org/10.1007/s00268-022-06655-1
  102. Ohira M, Kobayashi T, Hashimoto M, Tazawa H, Abe T, Oshita A, Kohashi T, Irei T, Oishi K, Ohdan H; Hiroshima Surgical study group of Clinical Oncology (HiSCO). Prognostic factors in patients with recurrent intrahepatic cholangiocarcinoma after curative resection: A retrospective cohort study. International Journal of Surgery. 2018;54(1):156-162.  https://doi.org/10.1016/j.ijsu.2018.04.058
  103. Bridgewater J, Fletcher P, Palmer DH, Malik HZ, Prasad R, Mirza D, Anthony A, Corrie P, Falk S, Finch-Jones M, Wasan H, Ross P, Wall L, Wadsley J, Evans TR, Stocken D, Stubbs C, Praseedom R, Ma YT, Davidson B, Neoptolemos J, Iveson T, Cunningham D, Garden OJ, Valle JW, Primrose J; BILCAP study group. Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study. Journal of Clinical Oncology. 2022;40(18):2048-2057. https://doi.org/10.1200/JCO.21.02568
  104. Hu LS, Zhang XF, Weiss M, Popescu I, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Koerkamp BG, Itaru E, Pawlik TM. Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology. 2019;26(8):2549-2557. https://doi.org/10.1245/s10434-019-07353-4
  105. Spolverato G, Kim Y, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Clark Gamblin T, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Tran TB, Wallis Marsh J, Pawlik TM. Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection. Annals of Surgical Oncology. 2016;23(1):235-243.  https://doi.org/10.1245/s10434-015-4642-9
  106. Nickkholgh A, Ghamarnejad O, Khajeh E, Tinoush P, Bruckner T, Kulu Y, Mieth M, Goeppert B, Roessler S, Weiss KH, Hoffmann K, Büchler MW, Mehrabi A. Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma. BJS Open. 2019;3(6):793-801.  https://doi.org/10.1002/bjs5.50217
  107. Bartsch F, Paschold M, Baumgart J, Hoppe-Lotichius M, Heinrich S, Lang H. Surgical Resection for Recurrent Intrahepatic Cholangiocarcinoma. World Journal of Surgery. 2019;43(4):1105-1116. https://doi.org/10.1007/s00268-018-04876-x
  108. Bartsch F, Eberhard J, Rückert F, Schmelzle M, Lehwald-Tywuschik N, Fichtner-Feigl S, Gaedcke J, Oldhafer KJ, Oldhafer F, Diener M, Mehrabi A, Settmacher U, Becker T, Keck T, Friess H, Strücker B, Opitz S, Lemke J, Schnitzbauer A, Lang H; German ICC Collaboration Group. Repeated resection for recurrent intrahepatic cholangiocarcinoma: A retrospective German multicentre study. Liver International. 2021;41(1):180-191.  https://doi.org/10.1111/liv.14682
  109. Ramouz A, Ali-Hasan-Al-Saegh S, Shafiei S, Fakour S, Khajeh E, Majlesara A, Adeliansedehi A, Probst P, Springfeld C, Chang DH, Rupp C, Carvalho C, Golriz M, Hoffmann K, Mehrabi A. Repeat liver resection for recurrent intrahepatic cholangiocarcinoma: meta-analysis. British Journal of Surgery. 2022;109(7):580-587.  https://doi.org/10.1093/bjs/znac075
  110. Langella S, Russolillo N, Ossola P, Luzzi AP, Casella M, Lo Tesoriere R, Ferrero A. Recurrence after Curative Resection for Intrahepatic Cholangiocarcinoma: How to Predict the Chance of Repeat Hepatectomy? Journal of Clinical Medicine. 2021;10(13):2820. https://doi.org/10.3390/jcm10132820
  111. Si A, Li J, Xing X, Lei Z, Xia Y, Yan Z, Wang K, Shi L, Shen F. Effectiveness of repeat hepatic resection for patients with recurrent intrahepatic cholangiocarcinoma: Factors associated with long-term outcomes. Surgery. 2017;161(4):897-908.  https://doi.org/10.1016/j.surg.2016.10.024
  112. Chu HH, Kim JH, Shin YM, Won HJ, Kim PN. Percutaneous Radiofrequency Ablation for Recurrent Intrahepatic Cholangiocarcinoma After Curative Resection: Multivariable Analysis of Factors Predicting Survival Outcomes. American Journal of Roentgenology. 2021;217(2):426-432.  https://doi.org/10.2214/AJR.20.23461
  113. Bekki Y, Von Ahrens D, Takahashi H, Schwartz M, Gunasekaran G. Recurrent Intrahepatic Cholangiocarcinoma — Review. Frontiers in Oncology. 2021;11:776863. https://doi.org/10.3389/fonc.2021.776863
  114. Ge Y, Jeong S, Luo GJ, Ren YB, Zhang BH, Zhang YJ, Shen F, Cheng QB, Sui CJ, Wang HY, Xia Q, Chen L. Transarterial chemoembolization versus percutaneous microwave coagulation therapy for recurrent unresectable intrahepatic cholangiocarcinoma: Development of a prognostic nomogram. Hepatobiliary & Pancreatic Diseases International. 2020;19(2):138-146.  https://doi.org/10.1016/j.hbpd.2020.02.005
  115. Edeline J, Lamarca A, McNamara MG, Jacobs T, Hubner RA, Palmer D, Groot Koerkamp B, Johnson P, Guiu B, Valle JW. Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysis. Cancer Treatment Reviews. 2021;99:102258. https://doi.org/10.1016/j.ctrv.2021.102258

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register


We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.